GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharming Group N.V. (PHAR) | 10/22/2026 1:01:40 AM | View | Financials | Earnings (Prelim) | WIRE | 3Q 2026 | Export Earnings Model | ||||
| Pharming Group N.V. (PHAR) | 4/13/2026 10:32:53 AM | Small | View | Financials | 20-F/A | SEC | Y 2025 ending: 12/31/2025 | Rev: $376,134,000 +26.6% | Assets $499,963,000 | EPS $0.00 | |
| Pharming Group N.V. (PHAR) | 4/2/2026 6:15:04 AM | Small | View | Financials | 20-F | SEC | Y 2025 ending: 12/31/2025 | Rev: $376,134,000 +26.6% | Assets $499,963,000 | EPS $0.00 | |
| Pharming Group N.V. (PHAR) | 5/8/2025 1:01:45 AM | View | Financials | Earnings | WIRE | 1Q 2025 | Rev $79 -99.9% | Assets $403,181 | EPS -$0.02 | Export Earnings Model | |
| Pharming Group N.V. (PHAR) | 4/4/2025 4:02:05 AM | Small | View | Financials | 20-F | SEC | Y 2024 ending: 12/31/2024 | Rev: $297,200,000 +21.1% | Assets $399,985,000 | EPS -$0.02 | |
| Pharming Group N.V. (PHAR) | 4/3/2025 1:01:56 AM | View | Financials | Earnings | WIRE | Y 2024 | Assets $399,985,000 | Export Earnings Model | |||
| Pharming Group N.V. (PHAR) | 3/13/2025 2:01:46 AM | View | Financials | Earnings | WIRE | Y 2024 | Assets $399,985,000 | Export Earnings Model | |||
| Pharming Group N.V. (PHAR) | 5/8/2024 1:01:15 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $55,586 | Assets $441,668 | EPS -$0.02 | Export Earnings Model | |
| Pharming Group N.V. (PHAR) | 4/4/2024 8:16:35 AM | Small | View | Financials | 20-F | SEC | Y 2023 ending: 12/31/2023 | Rev: $245,316,000 +19.3% | Assets $462,854,000 | EPS -$0.02 | |
| Pharming Group N.V. (PHAR) | 4/4/2024 1:01:30 AM | View | Financials | Earnings | WIRE | Y 2023 | Assets $462,854,000 | Export Earnings Model | |||
| Pharming Group N.V. (PHAR) | 3/14/2024 2:01:58 AM | View | Financials | Earnings | WIRE | Y 2023 | Assets $462,854,000 | Export Earnings Model | |||
| Pharming Group N.V. (PHAR) | 4/5/2023 7:10:10 AM | Small | View | Financials | 20-F | SEC | Y 2022 ending: 12/31/2022 | Rev: $205,622,000 +3.4% | Assets $425,797,000 | EPS $0.02 | |
| Pharming Group N.V. (PHAR) | 3/16/2023 2:03:16 AM | View | Financials | Earnings | WIRE | Y 2022 | Export Earnings Model | ||||
| Pharming Group N.V. (PHAR) | 10/27/2022 1:06:54 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Export Earnings Model | ||||
| Pharming Group N.V. (PHAR) | 4/6/2022 4:27:36 PM | Small | View | Financials | 20-F | SEC | Y 2021 ending: 12/31/2021 | Rev: $198,871,000 -6.3% | Assets $397,315,000 | EPS $0.02 | |
| Pharming Group N.V. (PHAR) | 4/7/2021 4:32:17 PM | Small | View | Financials | 20-F | SEC | Y 2020 ending: 12/31/2020 | Rev: $212,174,000 +12.0% | Assets $418,453,000 | EPS $0.06 |